Lower trabecular bone score is associated with an increased incidence of localized femoral periosteal thickening

[1]  H. Ishikawa,et al.  Cumulative incidence of femoral localized periosteal thickening (beaking) preceding atypical femoral fractures in patients with rheumatoid arthritis , 2020, Osteoporosis International.

[2]  Erik J. Geiger,et al.  Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. , 2020, The New England journal of medicine.

[3]  T. Yoshii,et al.  Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in "typical" atypical subtrochanteric femoral fracture: A proposed theory of atypical femoral fracture subtypes. , 2020, Bone.

[4]  G. Espinosa,et al.  Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis. , 2019, Rheumatology.

[5]  E. Schwartz,et al.  Dual-Energy X-Ray Absorptiometry Monitoring With Trabecular Bone Score: The 2019 ISCD Official Positions. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[6]  I. Narita,et al.  High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan , 2019, Rheumatology International.

[7]  M. Bouxsein,et al.  Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management. , 2019, Endocrine reviews.

[8]  F. Rivadeneira,et al.  Trabecular Bone Score and Hip Structural Analysis in Patients With Atypical Femur Fractures. , 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[9]  Kristin L. Popp,et al.  Cortical Bone Material Strength Index and Bone Microarchitecture in Postmenopausal Women With Atypical Femoral Fractures , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  I. Narita,et al.  Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients. , 2017, The Tohoku journal of experimental medicine.

[11]  A. Harris,et al.  Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial , 2017, Osteoporosis International.

[12]  H. Yoshikawa,et al.  Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis , 2017, Journal of Bone and Mineral Metabolism.

[13]  I. Narita,et al.  High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates , 2017, Osteoporosis International.

[14]  M. Koo,et al.  Trabecular Bone Score Reflects Trabecular Microarchitecture Deterioration and Fragility Fracture in Female Adult Patients Receiving Glucocorticoid Therapy: A Pre-Post Controlled Study , 2017, BioMed research international.

[15]  M. Yamazaki,et al.  Location of fractures and the characteristics of patients with atypical femoral fractures: analyses of 38 Japanese cases , 2017, Journal of Bone and Mineral Metabolism.

[16]  R. Marcus,et al.  Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy–Induced Osteoporosis Treated With Alendronate or Teriparatide , 2016, Arthritis & rheumatology.

[17]  Jacques P. Brown,et al.  A Meta‐Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  D. Bauer,et al.  Managing Osteoporosis in Patients on Long‐Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  I. Narita,et al.  The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates , 2016, Osteoporosis International.

[20]  N. Endo,et al.  Bilateral atypical femoral subtrochanteric fractures in a premenopausal patient receiving prolonged bisphosphonate therapy: evidence of severely suppressed bone turnover. , 2015, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[21]  R. Eastell,et al.  The impact of glucocorticoid therapy on trabecular bone score in older women , 2015, Osteoporosis International.

[22]  R. Winzenrieth,et al.  Bone status in glucocorticoid-treated men and women , 2015, Osteoporosis International.

[23]  N. Nagura,et al.  The incidence of and risk factors for developing atypical femoral fractures in Japan , 2015, Journal of Bone and Mineral Metabolism.

[24]  X. Guo,et al.  Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids. , 2014, The Journal of clinical endocrinology and metabolism.

[25]  J. Zanchetta,et al.  Assessment of Bone Microarchitecture in Postmenopausal Women on Long‐Term Bisphosphonate Therapy With Atypical Fractures of the Femur , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  Heinrich Resch,et al.  Trabecular Bone Score: A Noninvasive Analytical Method Based Upon the DXA Image , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  M. Iki,et al.  Trabecular Bone Score (TBS) Predicts Vertebral Fractures in Japanese Women Over 10 Years Independently of Bone Density and Prevalent Vertebral Deformity: The Japanese Population‐Based Osteoporosis (JPOS) Cohort Study , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  Thomas D Brown,et al.  Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  Yoshiya Tanaka,et al.  Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update , 2014, Journal of Bone and Mineral Metabolism.

[30]  W. Leslie,et al.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  J. Zerwekh,et al.  Severely suppressed bone turnover: a potential complication of alendronate therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[32]  M. Fukunaga,et al.  Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004) , 2004, Journal of Bone and Mineral Metabolism.

[33]  P. Meunier,et al.  Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid‐Induced and Postmenopausal Osteoporosis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.